Mitochondria in steatohepatitis

被引:304
作者
Pessayre, D
Berson, A
Fromenty, B
Mansouri, A
机构
[1] Hop Beaujon, INSERM U481, F-92118 Clichy, France
[2] Hop Beaujon, INSERM U481, F-92118 Clichy, France
[3] Hop Beaujon, Ctr Rech, Assoc Claude Bernard Hepatites Virales, F-92118 Clichy, France
关键词
cytokine; Fas; mitochondria; lipids; peroxidation; reactive oxygen species; steatosis; steatohepatitis;
D O I
10.1055/s-2001-12929
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
For the first time in history, populations in affluent countries may concomitantly indulge in rich food and physical idleness. Various combinations of obesity, diabetes, and hypertriglyceridemia, with insulin resistance as the common feature, cause hepatic steatosis, which can trigger necroinflammation and fibrosis. Patients with "primary" steatohepatitis exhibit ultrastructural mitochondrial lesions, decreased activity of respiratory chain complexes, and have impaired ability to resynthesize ATP after a fructose challenge. Mitochondria play a major role in fat oxidation and energy production but also leak reactive oxygen species (ROS) and are the main cellular source of ROS. In patients with steatosis, mitochondrial ROS may oxidize hepatic fat deposits, as suggested in animal models. Lipid peroxidation products impair the flow of electrons along the respiratory chain, which may cause overreduction of respiratory chain components, further increasing mitochondrial ROS formation and lipid peroxidation. Another vicious circle could involve ROS-induced depletion of antioxidants, impairing ROS inactivation. Blood vitamin E is decreased in some obese children with steatohepatitis, and serum transaminases improve after vitamin E supplementation. Steatohepatitis is also caused by alcohol abuse, drugs, and other causes. In "secondary" steatohepatitis, mitochondrial ROS formation is further increased as the causative disease itself directly increases ROS or first impairs respiration, which secondarily increases mitochondrial ROS formation. This "second hit" could cause more lipid peroxidation, cytokine induction, Fas ligand induction, and fibrogenesis than in primary steatohepatitis.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 151 条
[41]  
FINDOR J, 1973, ACTA HEPATO-GASTRO, V20, P200
[42]   Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia [J].
Fleury, C ;
Neverova, M ;
Collins, S ;
Raimbault, S ;
Champigny, O ;
LeviMeyrueis, C ;
Bouillaud, F ;
Seldin, MF ;
Surwit, RS ;
Ricquier, D ;
Warden, CH .
NATURE GENETICS, 1997, 15 (03) :269-272
[43]   Metabolic and nutritional considerations in nonalcoholic fatty liver [J].
Fong, DG ;
Nehra, V ;
Lindor, KD ;
Buchman, AL .
HEPATOLOGY, 2000, 32 (01) :3-10
[44]  
FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1371
[45]  
FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377
[46]   EVALUATION OF HUMAN BLOOD-LYMPHOCYTES AS A MODEL TO STUDY THE EFFECTS OF DRUGS ON HUMAN MITOCHONDRIA - EFFECTS OF LOW CONCENTRATIONS OF AMIODARONE ON FATTY-ACID OXIDATION, ATP LEVELS AND CELL-SURVIVAL [J].
FROMENTY, B ;
LETTERON, P ;
FISCH, C ;
BERSON, A ;
DESCHAMPS, D ;
PESSAYRE, D .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (03) :421-432
[47]   INHIBITION OF MITOCHONDRIAL BETA-OXIDATION AS A MECHANISM OF HEPATOTOXICITY [J].
FROMENTY, B ;
PESSAYRE, D .
PHARMACOLOGY & THERAPEUTICS, 1995, 67 (01) :101-154
[48]   HEPATIC MITOCHONDRIAL-DNA DELETION IN ALCOHOLICS - ASSOCIATION WITH MICROVESICULAR STEATOSIS [J].
FROMENTY, B ;
GRIMBERT, S ;
MANSOURI, A ;
BEAUGRAND, M ;
ERLINGER, S ;
ROTIG, A ;
PESSAYRE, D .
GASTROENTEROLOGY, 1995, 108 (01) :193-200
[49]   INVOLVEMENT OF THE CD95 (APO-1/FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE [J].
GALLE, PR ;
HOFMANN, WJ ;
WALCZAK, H ;
SCHALLER, H ;
OTTO, G ;
STREMMEL, W ;
KRAMMER, PH ;
RUNKELL, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1223-1230
[50]   Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice [J].
Gavrilova, O ;
Marcus-Samuels, B ;
Graham, D ;
Kim, JK ;
Shulman, GI ;
Castle, AL ;
Vinson, C ;
Eckhaus, M ;
Reitman, ML .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :271-278